Posted on January 22, 2020 |
“The main lobbying association for drug makers, the Pharmaceutical Research and Manufacturers of America, spent a record $28.9 million on lobbying last year as it pushed back on legislation meant to ...
Posted on January 7, 2020 |
“The hospital industry pushed back on the findings, the latest salvo in an ongoing battle over the program, which provider trade groups like the American Hospital Association and America’s ...
Posted on July 10, 2019 |
The 340B drug pricing program may discourage drug manufacturers from raising prices and instead may have the effect of reducing list prices for certain drugs. That’s according to a ...
Posted on June 24, 2019 |
“Rural hospitals are facing a crisis, as many close or struggle to stay on top of rising expenses. But a new study shows that savings from the 340B drug pricing ...
Posted on June 20, 2019 |
“At a recent hearing of the Senate Finance Committee, Chairman Sen. Chuck Grassley (R-Iowa) warned the seven assembled drug company executives not to point fingers: “It’s time for solutions,” ...